AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3157008 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole 160 mg and 800 mg respectively, twice daily for 10 days
Number of subjects: 40
Study 31621640 — intervention group
Group type: EXPERIMENTAL
Intervention: I‐ACE tool (experimental arm)
Number of subjects: 50
Study 31621640 — intervention group
Group type: COMPARATOR
Intervention: SLA methods (comparison arm)
Number of subjects: 50
Study 29987678 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 61
Study 29987678 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 61
Study 29987678 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in prandial FGF19
Number of subjects: 61
Study 26971035 — intervention group
Group type: EXPERIMENTAL
Intervention: rtPA group
Number of subjects: 18
Study 26971035 — intervention group
Group type: COMPARATOR
Intervention: non-rtPA group
Number of subjects: 18
Study 24676651 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous metamizole 1.5 g every 8 h during the first 24 postoperative hours
Number of subjects: 110
Study 24676651 — intervention group
Group type: COMPARATOR
Intervention: Intravenous paracetamol 1 g every 8 h during the first 24 postoperative hours
Number of subjects: 110
Study 19900742 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive patient-practitioner relationship
Number of subjects: 289
Study 19900742 — intervention group
Group type: COMPARATOR
Intervention: Experiential interview (additional opportunity to discuss illness)
Number of subjects: 289
Study 15599778 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone and amikacin (CA regimen)
Number of subjects: 224
Study 15599778 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin-tazobactam and amikacin (PTA regimen)
Number of subjects: 224
Study 12039127 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine-receptor blocker 8-sulfophenyltheophylline
Number of subjects: 16
Study 12039127 — intervention group
Group type: COMPARATOR
Intervention: Normal pregnancy
Number of subjects: 16
Study 12039127 — intervention group
Group type: EXPERIMENTAL
Intervention: Preeclampsia
Number of subjects: 16
Study 9692161 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine plus chlorpheniramine (CQ/CP)
Number of subjects: 100
Study 9692161 — intervention group
Group type: COMPARATOR
Intervention: Pyrimethamine/sulfadoxine (PS)
Number of subjects: 100
Study 7911143 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumen used for repeat infusions and injections
Number of subjects: 28
Study 7911143 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumen permanently connected to slow infusion of 0.9% NaCl
Number of subjects: 28
Study 7911143 — intervention group
Group type: COMPARATOR
Intervention: Catheter-tip cultures
Number of subjects: 28
Study 3293479 — intervention group
Group type: EXPERIMENTAL
Intervention: midazolam-fentanyl-N2O/O2 anesthesia
Number of subjects: 16
Study 3293479 — intervention group
Group type: COMPARATOR
Intervention: halothane-N2O/O2 anesthesia
Number of subjects: 16
Study 11314852 — intervention group
Group type: EXPERIMENTAL
Intervention: Women describing throat, neck or jaw pain
Number of subjects: 200
Study 11314852 — intervention group
Group type: EXPERIMENTAL
Intervention: Women giving accounts of breathlessness and other symptoms
Number of subjects: 200
Study 11314852 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender differences in language use
Number of subjects: 200
Study 31193184 — intervention group
Group type: EXPERIMENTAL
Intervention: B-CBCT-Office
Number of subjects: 0
Study 31193184 — intervention group
Group type: EXPERIMENTAL
Intervention: B-CBCT-Home
Number of subjects: 0
Study 31193184 — intervention group
Group type: COMPARATOR
Intervention: PTSD Family Education
Number of subjects: 0
Study 28857770 — intervention group
Group type: EXPERIMENTAL
Intervention: Group rehabilitation exercises supervised by a physical therapist
Number of subjects: 74
Study 28857770 — intervention group
Group type: COMPARATOR
Intervention: Home exercises
Number of subjects: 74
Study 26853137 — intervention group
Group type: EXPERIMENTAL
Intervention: Continue antihypertensive drugs
Number of subjects: 246
Study 26853137 — intervention group
Group type: COMPARATOR
Intervention: Stop antihypertensive drugs
Number of subjects: 246
Study 25046622 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipo-botulinum toxin instillation
Number of subjects: 62
Study 25046622 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 62
Study 22113647 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased daily water intake by 1.5 l
Number of subjects: 102
Study 22113647 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional water intake)
Number of subjects: 102
Study 20413122 — intervention group
Group type: EXPERIMENTAL
Intervention: Po-husk (14 g/d)
Number of subjects: 254
Study 20413122 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin (20 mg/d) added to Po-husk or placebo
Number of subjects: 254
Study 17666596 — intervention group
Group type: COMPARATOR
Intervention: Operative laparoscopy
Number of subjects: 60
Study 17666596 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically guided minilaparotomy
Number of subjects: 60
Study 15745138 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of Cndi in steps of 0.2 mS/cm
Number of subjects: 28
Study 11821217 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 0.1%
Number of subjects: 101
Study 11821217 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 0.2%
Number of subjects: 101
Study 11821217 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac 0.1%
Number of subjects: 101
Study 9701205 — intervention group
Group type: EXPERIMENTAL
Intervention: Retroperitoneal partial 'no-closure'
Number of subjects: 61
Study 9701205 — intervention group
Group type: COMPARATOR
Intervention: Closure
Number of subjects: 61
Study 8134281 — intervention group
Group type: EXPERIMENTAL
Intervention: 201Tl
Number of subjects: 37
Study 8134281 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc‐MIBI
Number of subjects: 37
Study 8134281 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT
Number of subjects: 37
Study 8134281 — intervention group
Group type: COMPARATOR
Intervention: Planar scintigraphy
Number of subjects: 37
Study 2674063 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin and Ornidazole (CO)
Number of subjects: 100
Study 2674063 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin and Placebo (CP)
Number of subjects: 100
Study 1091282 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate coronary care (nursed by CCU staff, resuscitation equipment available, efficient emergency call system)
Number of subjects: 1000
Study 1091282 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate coronary care
Number of subjects: 1000
Study 1091282 — intervention group
Group type: COMPARATOR
Intervention: Control group (discharged from CCU to general medical ward)
Number of subjects: 1000
Study 1091282 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1000
Study 31420724 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Pringle Maneuver (IPM)
Number of subjects: 176
Study 31420724 — intervention group
Group type: COMPARATOR
Intervention: No-Pringle Maneuver (NPM)
Number of subjects: 176
Study 29349980 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic debridement with continuous irrigation using sensitive antibiotics for 2-3 weeks
Number of subjects: 11
Study 29349980 — intervention group
Group type: COMPARATOR
Intervention: Open surgical debridement
Number of subjects: 11
Study 26745049 — intervention group
Group type: EXPERIMENTAL
Intervention: Back massage for 15 minutes per day for a week
Number of subjects: 44
Study 24460280 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Partner Program (8 weeks of training in health management, leadership, and coaching)
Number of subjects: 70
Study 24460280 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Partner Program
Number of subjects: 70
Study 24460280 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 70
Study 21488521 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational training program in affect regulation (n=8)
Number of subjects: 19
Study 21488521 — intervention group
Group type: COMPARATOR
Intervention: Inpatient treatment as usual (Control group, n=11)
Number of subjects: 19
Study 19784508 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 101
Study 19784508 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 101
Study 19784508 — intervention group
Group type: COMPARATOR
Intervention: Parasacral approach
Number of subjects: 101
Study 19784508 — intervention group
Group type: EXPERIMENTAL
Intervention: Probit regression for 95% of patients in parasacral approach
Number of subjects: 101
Study 19784508 — intervention group
Group type: EXPERIMENTAL
Intervention: Probit regression for 95% of patients in infragluteal-parabiceps approach
Number of subjects: 101
Study 19784508 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasacral SNB
Number of subjects: 101
Study 19784508 — intervention group
Group type: EXPERIMENTAL
Intervention: Infragluteal-parabiceps approach
Number of subjects: 101
Study 16539738 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypan blue (0.06%) used for posterior capsulorhexis with optic capture
Number of subjects: 35
Study 16539738 — intervention group
Group type: COMPARATOR
Intervention: No dye used for posterior capsulorhexis
Number of subjects: 35
Study 14982865 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacare restricted reimbursement for nebulised bronchodilators, steroids, and cromoglycate with individual patient exemptions.
Number of subjects: 449
Study 14982865 — intervention group
Group type: COMPARATOR
Intervention: Control group offered a six month exemption from the reimbursement restriction.
Number of subjects: 449
Study 10962052 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (3x400 mg orally per day), mesalazine (3x1 g orally per day), and betamethasone enema (once a day during 4 weeks)
Number of subjects: 60
Study 10962052 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine and betamethasone enema without metronidazole
Number of subjects: 60
Study 9276108 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic stimulation of the left vagus nerve (VNS) for 28 months
Number of subjects: 6
Study 9276108 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency stimulation of the left vagus nerve (VNS)
Number of subjects: 6
Study 8503246 — intervention group
Group type: EXPERIMENTAL
Intervention: 60, 125 or 250 micrograms/m2/day of rhGM‐CSF
Number of subjects: 46
Study 3662563 — intervention group
Group type: EXPERIMENTAL
Intervention: Trade name glucocorticoids (triamcinolone acetonide, fluocinolone acetonide, betamethasone valerate)
Number of subjects: 0
Study 3662563 — intervention group
Group type: COMPARATOR
Intervention: Generic formulations of triamcinolone acetonide, fluocinolone acetonide, and betamethasone valerate
Number of subjects: 0
Study 31424375 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Memory (WM) training (n-back training) for 15 sessions over five weeks
Number of subjects: 21
Study 31424375 — intervention group
Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 21
Study 31424375 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Memory (WM) training
Number of subjects: 21
Study 28778685 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 175
Study 28778685 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromopride
Number of subjects: 175
Study 28778685 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 175
Study 27802924 — intervention group
Group type: EXPERIMENTAL
Intervention: DBPTB allografts
Number of subjects: 101
Study 27802924 — intervention group
Group type: COMPARATOR
Intervention: 4SHS grafts
Number of subjects: 101
Study 24917632 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 33
Study 24917632 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 33
Study 22917825 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Coronary Intervention (PCI) with sirolimus‐eluting stent
Number of subjects: 301
Study 22917825 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 301
Study 20554511 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture (VA)
Number of subjects: 17
Study 20554511 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupuncture (PA)
Number of subjects: 17
Study 18396709 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound-healing hydrogel (group A)
Number of subjects: 60
Study 18396709 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (group B)
Number of subjects: 60
Study 15715531 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ferrous iron
Number of subjects: 427
Study 15715531 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg ferrous iron
Number of subjects: 427
Study 15715531 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg ferrous iron
Number of subjects: 427
Study 15715531 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg ferrous iron
Number of subjects: 427
Study 12646336 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 5 mg
Number of subjects: 1951
Study 12646336 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 1951
Study 10357371 — intervention group
Group type: EXPERIMENTAL
Intervention: SQV‐SGC 1200 mg three times per day
Number of subjects: 70
Study 10357371 — intervention group
Group type: COMPARATOR
Intervention: Indinavir 800 mg three times per day
Number of subjects: 70
Study 8706276 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 0
Study 1709781 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraumbilical vein administration of 10 IU of oxytocin in 20 ml of saline solution
Number of subjects: 220
Study 1709781 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 220
Study 6165817 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrasulcular brushing technique for 30 seconds daily for 49 days
Number of subjects: 24
Study 6165817 — intervention group
Group type: COMPARATOR
Intervention: Extrasulcular brushing technique for 30 seconds daily for 49 days
Number of subjects: 24
Study 30739006 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR) training
Number of subjects: 0
Study 30739006 — intervention group
Group type: COMPARATOR
Intervention: Active control groups
Number of subjects: 0
Study 26920858 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate of divergence analysis
Number of subjects: 150
Study 26920858 — intervention group
Group type: COMPARATOR
Intervention: Traditional perturbation and nonlinear methods
Number of subjects: 150
Study 25257236 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster-hole acetabular component
Number of subjects: 100
Study 25257236 — intervention group
Group type: COMPARATOR
Intervention: Solid-backed acetabular component
Number of subjects: 100
Study 23802121 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 26
Study 23802121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 22140499 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic formula group (regular formula containing a mixture of neutral oligosaccharides and pectin-derived acidic oligosaccharides)
Number of subjects: 0
Study 22140499 — intervention group
Group type: COMPARATOR
Intervention: Control formula group (regular formula without oligosaccharides)
Number of subjects: 0
Study 22140499 — intervention group
Group type: EXPERIMENTAL
Intervention: Both prebiotic and control groups
Number of subjects: 0
Study 22140499 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding group
Number of subjects: 0
Study 19622553 — intervention group
Group type: EXPERIMENTAL
Intervention: artemether-lumefantrine
Number of subjects: 175
Study 19622553 — intervention group
Group type: COMPARATOR
Intervention: quinine
Number of subjects: 175
Study 19622553 — intervention group
Group type: EXPERIMENTAL
Intervention: adherence levels of 80% or more
Number of subjects: 175
Study 19622553 — intervention group
Group type: EXPERIMENTAL
Intervention: adverse events
Number of subjects: 175
Study 17571831 — intervention group
Group type: EXPERIMENTAL
Intervention: Perforated, stretchable cloth tape (Hypafix)
Number of subjects: 294
Study 17571831 — intervention group
Group type: COMPARATOR
Intervention: Elastic spica bandage
Number of subjects: 294
Study 15057739 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CIP) 2 x 400 mg/day + Metronidazole (MET) 2 x 500 mg/day
Number of subjects: 114
Study 15057739 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 114
Study 15057739 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CIP) + Metronidazole (MET)
Number of subjects: 114
Study 11182039 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxifluridine 600 mg/body/day (group A)
Number of subjects: 37
Study 11182039 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxifluridine 800 mg/body/day (group B)
Number of subjects: 37
Study 9270458 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 day prescription of antibiotics
Number of subjects: 716
Study 9270458 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 716
Study 9270458 — intervention group
Group type: COMPARATOR
Intervention: Delayed prescription if sore throat had not started to settle after three days
Number of subjects: 716
Study 9270458 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics prescribed for sore throat during the previous year
Number of subjects: 716
Study 9270458 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer duration of illness (> 5 days)
Number of subjects: 716
Study 9270458 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics or delayed prescription
Number of subjects: 716
Study 8173754 — intervention group
Group type: EXPERIMENTAL
Intervention: WEB 2086 40 mg three times daily for 12 weeks
Number of subjects: 106
Study 8173754 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 8173754 — intervention group
Group type: COMPARATOR
Intervention: WEB 2086 and Placebo
Number of subjects: 106
Study 8173754 — intervention group
Group type: EXPERIMENTAL
Intervention: WEB 2086
Number of subjects: 106
Study 2906380 — intervention group
Group type: EXPERIMENTAL
Intervention: Sydnocarb (10 mg X 2 in air or 30 mg X 5 in water)
Number of subjects: 0
Study 2906380 — intervention group
Group type: EXPERIMENTAL
Intervention: Sydnogluton (sydnocarb 30 mg + glutamic acid 0.25 g X 5 in cold water)
Number of subjects: 0
Study 2906380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2179222 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildimac (new drug delivery system for silver sulfadiazine)
Number of subjects: 0
Study 2179222 — intervention group
Group type: COMPARATOR
Intervention: Silvadene cream 1% (twice-daily wound cleansing)
Number of subjects: 0
Study 1235149 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic high speed contraction
Number of subjects: 36
Study 1235149 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic low speed contraction
Number of subjects: 36
Study 1235149 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic
Number of subjects: 36
Study 1235149 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 31338676 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin A supplementation
Number of subjects: 0
Study 28159782 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenapanor (3 or 30 mg once daily or 1, 3, 10, or 30 mg twice daily)
Number of subjects: 162
Study 28159782 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 26115513 — intervention group
Group type: EXPERIMENTAL
Intervention: sertraline plus mirtazapine
Number of subjects: 36
Study 26115513 — intervention group
Group type: COMPARATOR
Intervention: sertraline plus placebo
Number of subjects: 36
Study 24176228 — intervention group
Group type: EXPERIMENTAL
Intervention: Baobab fruit extract (18.5 g and 37 g)
Number of subjects: 0
Study 24176228 — intervention group
Group type: EXPERIMENTAL
Intervention: Baobab fruit extract (1.88% added to white bread)
Number of subjects: 0
Study 20804437 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 128
Study 20804437 — intervention group
Group type: COMPARATOR
Intervention: Topical treatment
Number of subjects: 128
Study 19406374 — intervention group
Group type: EXPERIMENTAL
Intervention: High body shape concern group (n=23)
Number of subjects: 42
Study 19406374 — intervention group
Group type: COMPARATOR
Intervention: Low body shape concern group (n=19)
Number of subjects: 42
Study 19406374 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study 17320021 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen therapy
Number of subjects: 0
Study 17320021 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective estrogen receptor modulators (SERMs) such as raloxifene
Number of subjects: 0
Study 17320021 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0
Study 15036783 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure carbohydrates
Number of subjects: 15
Study 15036783 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure protein
Number of subjects: 15
Study 15036783 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure fat
Number of subjects: 15
Study 11192308 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocyte‐depletion filters added to the CPB circuit (treatment group)
Number of subjects: 20
Study 11192308 — intervention group
Group type: COMPARATOR
Intervention: Standard CPB without leucocyte‐depletion filters (control group)
Number of subjects: 20
Study 9203879 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine 40 micrograms.kg‐1
Number of subjects: 90
Study 9203879 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium 100 micrograms.kg‐1
Number of subjects: 90
Study 9203879 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 90